一项新的研究提示,C反应蛋白(CRP)水平与肺功能试验和呼吸包-年评估联合使用,可用于确定有进行性增生异常病变的烟民。CRP水平通常用于检测炎症,在增生型支气管病变和肺癌的发生中也起一定作用。但还不清楚CRP检测是否可预测病变的进展。加拿大温哥华市不列颠哥伦比亚癌症研究 A new study suggests that the use of C-reactive protein (CRP) levels in combination with lung function tests and respiratory bag-year assessments can be used to identify smokers with progressive dysplasia. CRP levels are usually used to detect inflammation and also play a role in the development of proliferative bronchial lesions and lung cancer. However, it is unclear whether the CRP test can predict the progression of the disease. Vancouver British Columbia Cancer Research